| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.28 | 0.2 |